Drug Database
Back to search

Belgium· BE-AMP-SAM528293-00

Imatinib Teva B.V. 400 mg

A imatinib product containing imatinib mesilate, registered in Belgium by Teva. The same ATC class is registered in 4 of our 19 countries.

ATC L01XE01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedImatinib Teva B.V. 400 mgATCL01XE01REGISTER NO.BE-AMP-SAM528293-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about imatinib mesilateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Imatinib is registered in 4 of 19 countries.

Countries holding a registration under ATC L01XE01 (imatinib), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose
Search imatinib products by name

Imatinib · ATC L01XE01

4 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Imatinib Mesilate
Manufacturer
Teva
Country
Belgium (BE)
ATC code
L01XE01
ATC class
Imatinib
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

770 interactions on record for imatinib.

Graded by severity as the source publishes them — 114 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check imatinib against other medicinesHow interaction checks work

Imatinib · interactions on record

770 records

  • 114 severe
  • 518 moderate
  • 23 minor
  • 111 info

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • EliglustatA16AX10severe
  • LonafarnibA16AX20severe

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Imatinib in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All imatinib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Imagerolan, Imatinib 1a Pharma
  • Bulgaria · Иматиниб Тева Фарма, Меаксин
  • Cyprus · Imarem, Imatinib Koanaa 100 Mg
  • Czechia · Imanivec, Imatinib Grindeks
  • Germany · Imanivec, Imatinib 1 A Pharma
  • Denmark · Bimatix, Imatinib "sandoz"
  • Estonia · Glipox, Imatinib Grindeks
  • Spain · Imatinib Cipla, Imatinib Farmalider
  • Finland · Bimatix, Imatinib Hexal
  • France · Imatinib Arrow Lab, Imatinib Bgr
  • United Kingdom (Northern Ireland) · Imatinib, Imatinib Amarox
  • Greece · Imatek, Imatinib Aenorasis
  • Croatia · Imakrebin, Meaxin
  • Hungary · Imaniver, Imatinib 1 A Pharma
  • Ireland · Imatinib Krka D.D., Imatinib Rowex
  • Iceland · Bimatix, Glivec
  • Italy · Imanivec, Imatinib Dr. Reddy’s
  • Liechtenstein · Glivec, Imatinib Accord
  • Lithuania · Glipox, Imatinib Grindeks
  • Luxembourg · Imatinib, Imatinib Eg
  • Latvia · Imatinib Grindeks, Imatinib Inteli
  • Malta · Imatinib Tad, Nibix
  • Netherlands · Bimatix, Imakrebin
  • Norway · Bimatix, Glivec
  • Poland · Imatenil, Meaxin
  • Portugal · Imatinib Aurobindo, Imatinib Aurovitas
  • Romania · Imakrebin, Imatinib Grindeks
  • Sweden · Bimatix, Imatinib Amarox
  • Slovenia · Meaxin
  • Slovakia · Imatinib Glenmark, Imatinib Grindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bc1c5665-657e-43a7-92b2-556e7bd3367f
GET /v1/drugs/bc1c5665-657e-43a7-92b2-556e7bd3367f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Imatinib Teva B.V. 400 mg",
  "name_fr": "Imatinib Teva B.V. 400 mg",
  "name_nl": "Imatinib Teva B.V. 400 mg",
  "amp_code": "SAM528293-00",
  "strengths": [
    "400.0000"
  ],
  "pack_count": 8,
  "substances": [
    "Imatinib Mesilate",
    "Imatinib"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Imatinib",
  "authorisation_numbers": [
    "EU/1/17/1243/039",
    "EU/1/17/1243/040"
  ]
}
API referenceMCP serverPlans

See everything about imatinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console